Revolutionizing Alzheimer's disease and clinical trials through biomarkers

The Alzheimer's Association's Research Roundtable met in May 2014 to explore recent progress in developing biomarkers to improve understanding of disease pathogenesis and expedite drug development. Although existing biomarkers have proved extremely useful for enrichment of subjects in clin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (Amst)
Autors principals: Mattsson, Niklas, Carrillo, Maria C., Dean, Robert A., Devous, Michael D., Nikolcheva, Tania, Pesini, Pedro, Salter, Hugh, Potter, William Z., Sperling, Reisa S., Bateman, Randall J., Bain, Lisa J., Liu, Enchi
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2015
Matèries:
Diagnostic Assessment & Prognosis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879481/
https://ncbi.nlm.nih.gov/pubmed/27239522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.09.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars